New Partners Initiative Translational HIV Research for Innovative Vaccines Ecosystem (NPI THRIVE)
Closed Posted
- Opportunity number
- 7200AA25RFA00001
- Applications due
- Award size
- $98,500,000
Opportunity facts
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- 501(c)(3) Nonprofits
Opportunity details come from Grants.gov. Updated .
About this opportunity
The United States Agency for International Development (USAID) is seeking applications for cooperative agreements under the New Partners Initiative Translational HIV Research for Innovative Vaccines Ecosystem (NPI THRIVE) Program. The program aims to accelerate the development of a safe and globally effective HIV vaccine by supporting a collaborative research ecosystem led by scientists and institutions from African countries with high HIV burdens. Applicants must be 501(c)(3) nonprofits and will be evaluated based on merit review criteria outlined in the Notice of Funding Opportunity (NOFO). The deadline for submitting concept notes is January 28, 2025, and USAID plans to hold co-creation workshops in March 2025 prior to the full application stage.
USAID intends to award at least two cooperative agreements, with up to $61.5 million for Objective 1 focusing on clinical research and $37 million for Objective 2 focused on preclinical research. At least 70% of direct costs must be incurred in African countries, with no more than 40% in any single country. Activities under Objective 1 must occur in at least four African countries, while Objective 2 requires activities in at least two African countries. Awards are anticipated to begin before September 30, 2025.
Synopsis
The United States Agency for International Development (USAID) is seeking applications for cooperative agreements from qualified entities to implement activities under the Translational HIV Research for Innovative Vaccines Ecosystem (NPI THRIVE) Program. NPI-THRIVE is a New Partnerships Initiative (NPI) Activity, meaning it encourages the use of innovative, locally-led approaches with new, nontraditional, and local partners. Eligibility for these awards is not restricted. The overall goal of NPI THRIVE is to accelerate the development of a safe and globally effective HIV vaccine by supporting a collaborative research ecosystem led by scientists and institutions from countries in Africa with high burdens of HIV working in close partnership with leading scientific institutions from other regions. This will be achieved through pursuing two complementary objectives, one focusing on clinical research and the other on preclinical research.
USAID intends to award at least two Applicants, at least one for each of the two objectives of this funding opportunity, based on the merit review criteria described in this NOFO and subject to a risk assessment. Parties interested in applying are encouraged to read this NOFO thoroughly to understand the type of program sought, application submission requirements, and selection process. This funding opportunity is posted on www.grants.gov, and may be amended. It is the Applicant's responsibility to regularly check the website to ensure they have the latest information pertaining to this NOFO and to ensure that the NOFO has been received from the internet in its entirety. USAID bears no responsibility for data errors resulting from transmission or conversion processes. If you have difficulty registering on www.grants.gov or accessing the NOFO, please contact the Grants.gov Helpdesk at 1-800-518-4726 or via email at support@grants.gov for technical assistance.
Files
| File | Type | Posted |
|---|---|---|
| Annex 7- Questions & Answers .pdf | ||
| Annex 1- Budget Template.xlsx | XLSX spreadsheet | |
| 7200AA25RFA00001- NPI THRIVE NOFO.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity